Thursday, April 4, 2024

ALS drug pulled from market in Canada, U.S. after failing late-stage clinical trial

Close up of the wheel of a wheelchair

Amylyx Pharmaceuticals has announced it will withdraw its amyotrophic lateral sclerosis (ALS) drug from the market in Canada and the U.S. following its failure in a late-stage clinical trial.



source https://www.cbc.ca/news/health/als-drug-withdrawn-relyvrio-albrioz-1.7163259?cmp=rss

No comments:

Post a Comment